SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Concerns about ongoing dilution and insider share sales are driving much of the discussion, with traders viewing the activity as a major overhang on Oklos valuation. Bulls counter that the Meta data-center power agreement, reactor construction progress, and potential regulatory and fuel milestones support the long-term nuclear-energy thesis, fueling debate over whether the stocks weakness reflects fundamentals or short-selling and market volatility.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Anticipation over Super Micros Form 10-K filing is dominating discussion, with traders focused on whether it will be submitted on time and whether it confirms remediation of internal-control and accounting concerns. Bulls view a clean filing as a step toward restoring credibility and validating the AI infrastructure growth story, while bears warn that unresolved weaknesses or a delay could intensify the governance overhang.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention is centered on the approaching 80th-event trigger for SELLASs REGAL Phase 3 trial, which would start the final analysis and precede topline results. Traders are divided after a bearish report questioned the trials design and statistical power, while bullish participants point to the delayed events and reported long survival; extensive platform-moderation controversy has amplified the debate.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

Hawkish Federal Reserve commentary and speculation about additional rate hikes are driving a sharp, sector-wide selloff in SoFi and other fintech stocks, with traders also citing options-related volatility. Bears are adding shorts and puts, while bulls argue rate hikes are already reflected in SoFis guidance and view the decline as a macro-driven buying opportunity.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

A sustained biotech rally, fueled by Moderna-related optimism and a series of sector buyouts, has pressured LABDs 3x inverse exposure and driven intense trading interest. Traders are divided between expecting an overbought XBI pullback amid elevated yields and arguing that continued biotech momentum and leverage decay make LABD primarily a short-term trading vehicle.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Anticipation of ERCOT Batch Zero conditional classifications for Ciphers Texas data-center projects is dominating the discussion, with traders viewing a favorable outcome as validation of its AI/HPC power pipeline and a potential catalyst for new hyperscaler leases. Sentiment remains divided: bulls see Texas power scarcity and stricter screening of speculative projects as a competitive moat, while bears cite regulatory uncertainty, data-center opposition, sector weakness and continued volatility.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Renewed U.S.-Iran strikes and escalating Strait of Hormuz tensions are driving attention, with traders focused on potential oil-supply disruption, higher inflation and Treasury yields, and increased odds of rate hikes weighing on the S&P 500. Some participants argue that a possible ceasefire or Venezuelan oil deal could support a rebound, leaving the community sharply divided on whether the geopolitical shock will produce a sustained selloff or another dip-buying opportunity.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is drawing attention as part of a broader semiconductor and AI rally following Nvidias strong results, with traders expecting sustained CPU and data-center demand to lift the company. The bullish view is tempered by concerns over potential semiconductor tariffs, interest rates, weak price action, and the lack of a confirmed IntelNvidia partnership or foundry deal.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Positive Phase 3 SHASTA-3 and SHASTA-4 results for plozasiran in severe hypertriglyceridemia are driving attention, with the studies meeting key endpoints and showing substantial triglyceride reductions and fewer acute pancreatitis events. The community is broadly bullish on a potential label expansion and Arrowheads broader RNAi platform, though some traders cite sell-the-news pressure, competition from Ionis, and heavy market volatility.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is drawing attention after licensing its opakalim/Kv7 epilepsy program to SK Biopharmaceuticals for substantial upfront cash, with SK assuming development costs and Biohaven retaining milestone and royalty potential. Traders view the deal as reducing near-term financing and dilution risk, while skeptics argue it gives up some upside and leaves obesity and future epilepsy data as the key catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


hu88ucom

HU88